@inbook{inbook,
  author = {Lehman L F and Vuagnat H},
  title = {Hansen{\textquoteright}s Disease (Leprosy)},
  abstract = {Hansen{\textquoteright}s disease (HD), also known as leprosy, is a chronic disease caused by a
slowly multiplying bacillus, Mycobacterium leprae, mainly affecting skin, periph-
eral nerves, mucosa of the upper respiratory tract, and eyes. (1) Primary nerve
impairments and disability can be prevented or minimised when disease is diag-
nosed early and managed adequately. (1{\textendash}3) The incubation period of the disease
is about five years, but symptoms can take as long as 20 years to appear. (1) The
World Health Organization (WHO) recommends MDT (multi-drug therapy) con-
sisting of two or three drugs: dapsone and rifampicin for all plus clofazimine for
multibacillary disease.},
  year = {2020},
  journal = {Wound and Lymphoedema Management: Focus on Resource-limited Settings},
  edition = {2nd Edition},
  chapter = {16},
  publisher = {World Alliance for Wound and Lymphedema Care},
  isbn = {978-87-971974-1-7},
  url = {https://wawlc.org/fileadmin/user_upload/WAWLC/WAWLC_Lymphoedema_Report_17x24_FINAL_Electr.pdf$\#$page=118},
  language = {eng},
}